LRR | p | DM | p | |
---|---|---|---|---|
HR (95% CI) | HR (95% CI) | |||
Age (≤40 vs. >40) | 1.75 (1.16–2.66) | .008 | 1.69 (1.21–2.36) | 0.002 |
Tumor location (inner quadrant vs. non-inner quadrant) | 1.92 (1.32–2.79) | .001 | 1.48 (1.09–2.01) | 0.012 |
Positive lymph node (2–3 vs. 1) | 1.73 (1.21–2.47) | .003 | ||
Lympho-vascular invasion (yes vs. no) | 1.44 (0.97–2.16) | 0.074 | ||
Stage (AJCC 8th ed.) | ||||
Ia | Reference | Reference | ||
Ib-IIa | 2.10 (1.23–3.56) | .006 | 1.45 (1.01–2.08) | 0.044 |
IIb-IIIa | 5.95 (3.46–10.24) | < .001 | 3.34 (2.26–4.93) | < 0.001 |